NL-OMON47653已完成不适用
A post market clinical follow-up study with the Optimys Stem, with initial RSA analysis - Optimys Trial
Stichting SCORE0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Suffer from primary or secondary coxarthrosis.
- •Be ready to participate in the follow-up examinations mentioned above
- •Be between 18 and 85 years old at the time of inclusion
- •Be a candidate for a primary implantation of a hip endoprosthesis
- •Be expected to recover completely
- •Have a BMI of 35 or less
排除标准
- •Simultaneous participation in another clinical study or documentation with other orthopaedic implants of competitors.
- •Suffer from the exclusion criteria: sepsis or malignant tumours.
- •Have an ASA Classification > 3.
- •Have a revision surgery
研究者
相似试验
招募中
不适用
A post market clinical follow-up study with the aneXys ceramys inlay DEM16.7M16.1Other secondary coxarthrosisOther primary coxarthrosisDRKS00018809Mathys Orthopädie GmbH150
已完成
不适用
A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlayM16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00021508Mathys AG Bettlach150
已完成
不适用
Post-market clinical follow-up study evaluating the efficacy and safety of the wearable cardioverter-defibrillator (WCD) medical device 'LifeVest' in real-life settings in FranceISRCTN91372291ZO550
已完成
不适用
Post Market Clinical Follow-up study of the use of the vaginal cream Remifemin® FeuchtCreme (RFC)Complaints due to dryness of the vagina and the outer genital area (dry feeling, burning sensation, pain during sexual intercourse, or itching), as developed, for example, during the menopause.Facilitation of sexual intercourse.Physical support of the healing process of minor wounds and small inflammations of the vaginal skin.N89.8Other specified noninflammatory disorders of vaginaDRKS00006888Schaper & Brümmer GmbH & Co. KG230
已完成
不适用
Post-market clinical follow-up investigation of the marketed Extended Range of Vision IOL (Intraocular lens)h25H26Senile cataractOther cataractDRKS00005742Abbott Medical Optics Inc.147